Trending NewsTrending NewsNASDAQ:BCPC Balchem (BCPC) Stock Price, News & Analysis $177.00 +3.77 (+2.18%) Closing price 10/23/2026 04:00 PM EasternExtended Trading$177.08 +0.08 (+0.05%) As of 10/23/2026 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Balchem Stock (NASDAQ:BCPC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Balchem alerts:Sign Up Key Stats Today's Range$173.09▼$177.4550-Day Range$163.69▼$181.2852-Week Range$147.18▼$183.90Volume717,772 shsAverage Volume278,669 shsMarket Capitalization$5.64 billionP/E Ratio33.33Dividend Yield0.54%Price Target$197.33Consensus RatingBuy Company Overview Balchem Corporation is a specialty ingredients and products company that develops, manufactures and markets nutritional, health and performance products for customers in the food, nutrition, animal health and industrial markets. The company uses technologies including microencapsulation, chelation and other formulation processes to improve the stability, delivery and functionality of ingredients. Balchem’s Human Nutrition and Health business supplies minerals, vitamins, choline, methylfolate and other specialty nutrients used in dietary supplements, functional foods, beverages and pharmaceutical applications. Its Animal Nutrition and Health business provides nutritional ingredients, trace minerals, encapsulated products and other solutions designed to support animal health, feed efficiency and livestock production. The company’s Specialty Products business serves industrial and commercial customers with products used in areas such as water treatment, food processing, personal care and other specialized applications. Balchem was founded in 1967 and is headquartered in New Hampton, New York. It serves customers in the United States and international markets, and is led by President and Chief Executive Officer Ted W. Harris Jr.AI Generated. May Contain Errors. Read More Balchem Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks79th Percentile Overall ScoreBCPC MarketRank™: 3.9464860515 of 5 starsBalchem scored higher than 79% of companies evaluated by MarketBeat, and ranked 91st out of 226 stocks in the materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingBuy Consensus RatingBalchem has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 strong buy rating, 3 buy ratings, 1 hold rating, and no sell ratings.Upside PotentialBalchem has a consensus price target of $197.33, representing about 11.5% upside from its current price of $177.00.Amount of Analyst CoverageBalchem has only been the subject of 3 research reports in the past 90 days.Read more about Balchem's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth5.49% Earnings GrowthEarnings for Balchem are expected to grow by 5.49% in the coming year, from $5.83 to $6.15 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Balchem is 33.33, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.39.Price to Earnings Ratio vs. SectorThe P/E ratio of Balchem is 33.33, which means that it is trading at a more expensive P/E ratio than the Materials sector average P/E ratio of about 22.45.Price to Earnings Growth RatioBalchem has a PEG Ratio of 3.20. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBalchem has a P/B Ratio of 4.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.57% of the float of Balchem has been sold short.Short Interest Ratio / Days to CoverBalchem has a short interest ratio ("days to cover") of 2.08, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Balchem has recently decreased by 20.49%, indicating that investor sentiment is improving significantly. Dividend3.3 / 5Dividend StrengthStrong Dividend YieldBalchem has a dividend yield of 0.54%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthBalchem has been increasing its dividend for 16 years.Dividend CoverageThe dividend payout ratio of Balchem is 18.86%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Balchem will have a dividend payout ratio of 15.61% next year. This indicates that Balchem will be able to sustain or increase its dividend.Read more about Balchem's dividend. News and Social Media2.1 / 5News Sentiment0.43 News SentimentBalchem has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Materials companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Balchem this week, compared to 3 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Balchem insiders have not sold or bought any company stock.Percentage Held by Insiders1.65% of the stock of Balchem is held by insiders.Percentage Held by Institutions87.91% of the stock of Balchem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Balchem's insider trading history. Receive BCPC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BCPC Stock News HeadlinesBalchem (BCPC) Stock Can Q3 Earnings Spark A Bigger Rerating?October 25 at 7:36 AM | uk.finance.yahoo.comBalchem: Record Sales, Great Fundamentals, Priced Fully, HoldOctober 24 at 10:31 AM | seekingalpha.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.October 25 at 1:00 AM | Porter & Company (Ad)Balchem Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026October 23 at 10:51 PM | marketscreener.comMBalchem Earnings Call Highlights Record Growth And StrengthOctober 23 at 8:31 PM | tipranks.comBalchem (BCPC) Q3 2026 Earnings Call TranscriptOctober 23 at 5:48 PM | finance.yahoo.comBalchem Corporation (BCPC) Q3 2026 Earnings Call TranscriptOctober 23 at 3:00 PM | seekingalpha.comBalchem: 3 Key Takeaways for Long-Term InvestorsOctober 23 at 2:12 PM | fool.comSee More Headlines BCPC Stock Analysis - Frequently Asked Questions How have BCPC shares performed this year? Balchem's stock was trading at $153.36 at the start of the year. Since then, BCPC stock has increased by 15.4% and is now trading at $177.00. How were Balchem's earnings last quarter? Balchem Corporation (NASDAQ:BCPC) issued its quarterly earnings data on Friday, October, 23rd. The basic materials company reported $1.57 EPS for the quarter, topping the consensus estimate of $1.43 by $0.14. The basic materials company had revenue of $290.66 million for the quarter, compared to analyst estimates of $289.25 million. Balchem had a trailing twelve-month return on equity of 13.80% and a net margin of 15.14%. Read the conference call transcript. Does Balchem have any subsidiaries? Balchem subsidiaries include Zumbro River Brand Inc., Chemogas Holding NV, Bioscreen technologies, Innovative Food Processors, Chol-Mix Kft, Albion Laboratories Inc., SensoryEffects, and more. Who are Balchem's major shareholders? Top institutional shareholders of Balchem include Congress Asset Management Co. (1.58%), Assenagon Asset Management S.A. (1.17%), Salem Investment Counselors Inc. (0.23%) and Vest Financial LLC (0.14%). Insiders that own company stock include Theodore L Harris, Gunsteren Job Leonard Van, David B Fischer, William A Backus and Michael Robert Sestrick. View institutional ownership trends. How do I buy shares of Balchem? Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Balchem own? Based on aggregate information from My MarketBeat watchlists, some other companies that Balchem investors own include AbbVie (ABBV), Mastercard (MA), Oracle (ORCL), NVIDIA (NVDA), A. O. Smith (AOS), Badger Meter (BMI) and Adobe (ADBE). Company Calendar Last Earnings10/23/2026Today10/25/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 3 weeks, BCPC's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMaterials Industry Chemicals Sub-IndustrySpecialty Chemicals Current SymbolNASDAQ:BCPC Previous SymbolNASDAQ:BCPC CIK9326 Webwww.balchem.com Phone(845) 326-5600Fax845-326-5717Employees1,352Year Founded1967Price Target and Rating Average Price Target for Balchem$197.33 High Price Target$215.00 Low Price Target$162.00 Potential Upside/Downside+11.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)$5.09 Trailing P/E Ratio33.33 Forward P/E Ratio30.36 P/E Growth3.2Net Income$154.85 million Net Margins15.14% Pretax Margin19.56% Return on Equity13.80% Return on Assets10.55% Debt Debt-to-Equity Ratio0.14 Current Ratio2.66 Quick Ratio1.56 Sales & Book Value Annual Sales$1.04 billion Price / Sales5.44 Cash Flow$6.59 per share Price / Cash Flow26.84 Book Value$38.83 per share Price / Book4.56Miscellaneous Outstanding Shares31,880,000Free Float31,352,000Market Cap$5.64 billion OptionableOptionable Beta0.85 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:BCPC) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored$0. Later: $29.97.Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that l...Profits Run | SponsoredThe $100 Stock Behind Elon's Next MoveA small, publicly traded supplier trading under $100 a share has reportedly worked alongside Elon Musk for mor...Paradigm Press | SponsoredEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredWhy Gerardo Del Real says wait before buying uranium stocksGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Balchem Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Balchem With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.